Crispr Therapeutics AG (CRSP) — Free Cash Flow Generation Index
Crispr Therapeutics AG (CRSP) has a Free Cash Flow Generation Index of 0.99x as of March 2024. Free cash flow of $109.03 Million represents 1% of operating cash flow ($109.75 Million). Explore Crispr Therapeutics AG capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Crispr Therapeutics AG Free Cash Flow Generation Index (2015–2021)
Historical FCF Generation Index trend for Crispr Therapeutics AG across 3 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Crispr Therapeutics AG.
Annual Free Cash Flow Generation for Crispr Therapeutics AG (2015–2021)
Year-by-year Free Cash Flow Generation Index for Crispr Therapeutics AG. Check Crispr Therapeutics AG (CRSP) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.85x | $457.27 Million | $538.97 Million | $81.70 Million | ▼ -3.8% |
| 2019 | 0.88x | $49.99 Million | $56.68 Million | $6.68 Million | ▼ -10.0% |
| 2015 | 0.98x | $58.27 Million | $59.43 Million | $1.15 Million | — |